Pharmaceuticals - Community Register


Community list of not active medicinal products for human use


Product information

Invented name: Triacelluvax
Auth. number : EU/1/98/088
Active substance : combined diphtheria, tetanus, and acellular pertussis vaccine
ATC: Anatomical main group: J - General antiinfectives for systemic use
Therapeutic subgroup: J07 - Vaccines
Pharmacological subgroup: J07C - Bacterial and viral vaccines, combined
Chemical subgroup: J07CA - Bacterial and viral vaccines, combined
Chemical substance: J07CA01 - natamycin
(See WHO ATC Index)
Indication: Active immunisation of children from 6 weeks up to 7 years of age against diphteria, tetanos and pertussis
Marketing Authorisation Holder: Chiron spa
via Fiorentina 1, 53100 Sienne, Italia
EPAR and active package presentations

Package presentations

Information about presentations can be found in the website of the European Medicines Agency under the section "Product Information".
Likewise, presentations on which there has been a Commission decision are referred in the Summary of Product Characteristics (Annex I to the Commission Decision granting the marketing authorisation) which is available in the Community Register.

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
14/01/1999 Centralised - Authorisation EMEA/H/C/181 (1999)38 of 11/01/1999
19/12/2000 Centralised - Variation EMEA/H/C/181/II/1 (2000)3510 of 18/12/2000
31/01/2002 Centralised - Withdrawal (2002)403 of 28/01/2002